CD274 and neoplasm: Additionally, oncogenic activation of MYC, AKT, and K-RAS can contribute to PD-L1 expression of tumor cells, which inhibits immune surveillance (Casey et al, 2016; Coelho et al, 2017; Parsa et al, 2007).